Modes of Neovascularization in Tumors and Clinical Translation of Antiangiogenic Therapy

作者: R.K. Jain , D. Fukumura , D.G. Duda

DOI: 10.1016/B978-0-12-386456-7.05502-7

关键词: Vascular endothelial growth factorImmunologyCancer researchTumor microenvironmentCancerBiologyVasculogenesisMetastasisEndothelial progenitor cellNeovascularizationAngiogenesis

摘要: Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Recently, our understanding molecular mechanisms angiogenesis has increased at an explosive rate led approval antiangiogenic drugs for cancer eye diseases. So far, hundreds thousands patients have benefited from blockers angiogenic protein vascular endothelial growth factor, limited efficacy resistance remain outstanding problems. Recent studies shown new targets principles, which may provide avenues improving therapeutic benefit strategies. Our group others demonstrated that blood lymphatic vasculature, fibroblasts, immune cells, extracellular matrix associated with tumors are abnormal, together create a hostile tumor microenvironment. Antiangiogenic agents – originally designed starve can transiently ‘normalize’ alleviate hypoxia, improve outcome various therapies.

参考文章(276)
George D. Yancopoulos, Guillermo García-Cardeña, Andreas Papapetropoulos, Peter C. Maisonpierre, Thomas J. Dengler, William C. Sessa, Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Laboratory Investigation. ,vol. 79, pp. 213- 223 ,(1999)
M. A. Swartz, D. A. Berk, R. K. Jain, Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory American Journal of Physiology-heart and Circulatory Physiology. ,vol. 270, ,(1996) , 10.1152/AJPHEART.1996.270.1.H324
Shideng Bao, Qiulian Wu, Roger E. McLendon, Yueling Hao, Qing Shi, Anita B. Hjelmeland, Mark W. Dewhirst, Darell D. Bigner, Jeremy N. Rich, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature. ,vol. 444, pp. 756- 760 ,(2006) , 10.1038/NATURE05236
Betty Li, Alshad S. Lalani, Thomas C. Harding, Bo Luan, Kathryn Koprivnikar, Guang Huan Tu, Rodney Prell, Melinda J. VanRoey, Andrew D. Simmons, Karin Jooss, Vascular Endothelial Growth Factor Blockade Reduces Intratumoral Regulatory T Cells and Enhances the Efficacy of a GM-CSF–Secreting Cancer Immunotherapy Clinical Cancer Research. ,vol. 12, pp. 6808- 6816 ,(2006) , 10.1158/1078-0432.CCR-06-1558
Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, Takashi Sasaki, Hirofumi Kogure, Hiroshi Yagioka, Koji Miyabayashi, Suguru Mizuno, Keisuke Yamamoto, Dai Mouri, Kazumichi Kawakubo, Natsuyo Yamamoto, Kenji Hirano, Naoki Sasahira, Keisuke Tateishi, Minoru Tada, Kazuhiko Koike, Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1 Cancer Science. ,vol. 103, pp. 1489- 1492 ,(2012) , 10.1111/J.1349-7006.2012.02311.X
J. M. Tse, G. Cheng, J. A. Tyrrell, S. A. Wilcox-Adelman, Y. Boucher, R. K. Jain, L. L. Munn, Mechanical compression drives cancer cells toward invasive phenotype. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 109, pp. 911- 916 ,(2012) , 10.1073/PNAS.1118910109
Raghu Kalluri, Michael Zeisberg, Fibroblasts in cancer Nature Reviews Cancer. ,vol. 6, pp. 392- 401 ,(2006) , 10.1038/NRC1877
Kyrre E Emblem, Kim Mouridsen, Atle Bjornerud, Christian T Farrar, Dominique Jennings, Ronald J H Borra, Patrick Y Wen, Percy Ivy, Tracy T Batchelor, Bruce R Rosen, Rakesh K Jain, A Gregory Sorensen, Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nature Medicine. ,vol. 19, pp. 1178- 1183 ,(2013) , 10.1038/NM.3289
Yuki Hamano, Michael Zeisberg, Hikaru Sugimoto, Julie C Lively, Yohei Maeshima, Changqing Yang, Richard O Hynes, Zena Werb, Akulapalli Sudhakar, Raghu Kalluri, Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin Cancer Cell. ,vol. 3, pp. 589- 601 ,(2003) , 10.1016/S1535-6108(03)00133-8